Its stock has done well of late, but Scotia analyst Kevin Krishnaratne thinks there is still money to be made on Dye and Durham (Dye and Durham Stock Quote, Chart, News, Analysts, Financials TSX:DND).
As reported by the Globe and Mail, the analyst April 12 reiterated his “Sector Outperform” rating and price target of $24.00 on DND.
“Shares have performed well post Q2 results mid-Feb (up 30 per cent), but we continue to see further upside with the stock trading at 7.6 times calendar 2024 estimated Adj. EBITDA and 11.8-per-cent CY24 FCF yield (13.7-per-cent PF interest cost savings via recent debt refinancing),” Krishnaratne added. “Additionally, we still see opportunities for even further balance sheet optimizations via the sale of non-core assets and other initiatives to deleverage and drive FCF upside.”
The analyst said financially, DND is set up for the foreseeable future.
““We view DND’s recently closed refinancing transactions (8.625-per-cent US$555-million senior secured notes due 2029, US$350-million term loan maturing 2031, CAD$105-million revolver maturing 2029), in addition to the repayment of prior existing facilities with Ares as continued steps in the right direction to enhance the company’s balance sheet flexibility,” he wrote. “Although leverage remains elevated at 4.78 times net debt to LTM [last 12-month] Further Adj. EBITDA as at Dec. 31 per company calculations, the refinancing moves eliminate prior risks related to the Ares facility maturity date being accelerated (to 2025 from 2026) if DND’s 2026 debentures were to remain outstanding. Furthermore, given how DND now intends to repurchase the remaining $185-million 2026 debentures, there is a long window until the company’s next debt related maturities, those being the 6.50-per-cent 2028 debentures. We note that there is a new springing maturity in place for the new revolver (2029) and term loan (2031), which may both see an acceleration in their maturity within 91 days of the US$555-million senior secured notes, if the latter are not repaid, extended, refinanced, or replaced prior to their due date.”
At press time, shares of Dye and Durham were down 1.5% to $15.64.
Stifel analyst Justin Keywood said in an April 23 update that management commentary from WELL Health Technologies (WELL Health Technologies… [Read More]
iA Global Asset Management portfolio manager Dan Rohinton told BNN Bloomberg’s Market Call on April 21 that Taiwan Semiconductor (Taiwan… [Read More]
Kingwest & Company managing director Tim Regan told BNN Bloomberg’s Market Call on April 20 that EQB (EQB Stock Quote,… [Read More]
National Bank of Canada Capital Markets analyst Cameron Doerksen said in a note ahead of Cargojet’s (Cargojet Stock Quote, Chart,… [Read More]
Roth Capital analyst Scott Searle reiterated a “Buy” rating and $85.00 12-month price target on Calix (Calix Stock Quote, Chart,… [Read More]
In an April 20 sector update, Paradigm Capital analyst Daniel Rosenberg said small-cap technology is showing signs of a risk… [Read More]